Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antidepressant discontinuation syndromes.

P M Haddad1

  • 1Cromwell House, Mental Health Services of Salford, Eccles, England.

Drug Safety
|May 12, 2001
PubMed
Summary

Antidepressant discontinuation symptoms are common and can cause morbidity. Gradual tapering and patient education are key preventative strategies, with symptomatic treatment for severe cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimising Nutritional Psychiatry Treatment: Investigating the Mediterranean Diet to Improve Symptoms of Major Depressive Disorder (OPTIMISM): A double-blind sham-controlled randomised feeding trial protocol.

The British journal of nutrition·2026
Same author

A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis.

Translational psychiatry·2020
Same author

Antipsychotic drug use and pneumonia: Systematic review and meta-analysis.

Journal of psychopharmacology (Oxford, England)·2018
Same author

BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment.

Journal of psychopharmacology (Oxford, England)·2016
Same author

Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.

Journal of psychopharmacology (Oxford, England)·2016
Same author

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.

Journal of psychopharmacology (Oxford, England)·2015

Area of Science:

  • Psychiatry
  • Clinical Pharmacology

Background:

  • Discontinuation symptoms are frequently observed across various antidepressant classes, including tricyclic antidepressants, monoamine oxidase inhibitors, and selective serotonin reuptake inhibitors (SSRIs).
  • These symptoms can manifest shortly after dose reduction or abrupt cessation, presenting a clinical challenge due to potential misdiagnosis and impact on future treatment adherence.

Purpose of the Study:

  • To review the characteristics, clinical relevance, and management strategies for antidepressant discontinuation syndromes.
  • To highlight the need for further systematic research to establish evidence-based recommendations.

Main Methods:

  • Review of existing literature and expert opinion on antidepressant discontinuation symptoms.
  • Analysis of reported symptom clusters, onset patterns, and management approaches.

Main Results:

  • Discontinuation syndromes present with diverse symptoms varying by drug class, typically emerging within days of stopping or reducing medication.
  • Preventative measures include gradual tapering and patient/provider education; symptomatic treatment or reinstatement is effective for severe reactions.
  • Switching to fluoxetine is a potential strategy for SSRI/venlafaxine discontinuation, and neonatal symptoms require consideration in prescribing during pregnancy.

Conclusions:

  • Antidepressant discontinuation syndromes are clinically significant, necessitating careful management through tapering and education.
  • Further research is crucial to develop a robust evidence base for managing these symptoms and informing clinical practice.

Related Experiment Videos